Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Abstract

Triple negative breast cancer (TNBC) is a heterogeneous tumor characterized by early recurrence, high invasion, and poor prognosis. Currently, its treatment includes chemotherapy, which shows a suboptimal efficacy. However, with the increasing studies on TNBC subtypes and tumor molecular biology, great progress has been made in targeted therapy for TNBC. The new developments in the treatment of breast cancer include targeted therapy, which has the advantages of accurate positioning, high efficiency, and low toxicity, as compared to surgery, radiotherapy, and chemotherapy. Given its importance as cancer treatment, we review the latest research on the subtypes of TNBC and relevant targeted therapies.

• Authors: Chia-Jung Li, Yen-Dun Tony Tzeng, Yi-Han Chiu, Hung-Yu Lin, Ming-Feng Hou, Pei-Yi Chu
• Journal: Cancers (Cancers (Basel)) Vol. 13 Issue 12 (Jun 14 2021) ISSN: 2072-6694 [Print] Switzerland
• PMID: 34198652 (Publication Type: Journal Article, Review)